Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
Go back to Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress| (NASDAQ: HELP) | Delayed: 10.09 +0.08 (0.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.01 | 52 Week High | $ | |||
| Open | $10.10 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $9.92 | EPS | $ | |||
| Volume | 988,041 | |||||
